Managing Menopausal Symptoms in Breast Cancer Survivors

Abstract

Symptoms of estrogen deprivation commonly occur in breast cancer survivors as a result of natural menopause, or menopause that is precipitated prematurely by chemotherapy or anti-estrogen therapy with tamoxifen. In this research program, we are evaluating the role of a comprehensive menopausal assessment (CMA) and intervention program for management of menopausal symptoms in breast cancer survivors. During the past funding year, we have continued recruiting women and randomizing them into the experimental or usual care groups. The experimental group receives immediate assessment and intervention for their symptoms, while the usual care group receives no menopause related intervention during a four month period of observation. Systematic assessment of each breast cancer survivor assigned to the intervention group permits treatment of multiple symptoms simultaneously with a variety of non-estrogen pharmacologic, educational and behavioral interventions. We will be assessing the impact of the intervention on quality of life and the resolution of specific menopausal symptoms.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1997
Accession Number
ADA341366

Entities

People

  • Patricia A. Ganz

Organizations

  • University of California, Los Angeles

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Animals
  • Biomedical Research
  • Breast Cancer
  • California
  • Classification
  • Deoxyribonucleic Acids
  • Federal Law
  • Laboratory Animals
  • Maryland
  • Materials
  • Molecules
  • Neoplasms
  • Recombinant Dna
  • Security
  • Standards

Fields of Study

  • Medicine

Readers

  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.